Revance(RVNC) - 2019 Q3 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2019 Earnings Conference Call November 4, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of IR & Corporate Communications Mark Foley - President & CEO Tobin Schilke - CFO & Principal Accounting Officer Abhay Joshi - COO Dustin Sjuts - Head of Commercial, Aesthetics & Therapeutics Conference Call Participants Annabel Samimy - Stifel David Amsellem - Piper Jaffray Jacob Hughes - Wells Fargo Stacy Ku - Cowen & Company Douglas Tsao - H.C. Wainwr ...